Skip to main content

Pharmacogenetics of Clopidogrel: An Unresolved Issue.

Publication ,  Journal Article
Pereira, NL; Geske, JB; Mayr, M; Shah, SH; Rihal, CS
Published in: Circ Cardiovasc Genet
April 2016

Duke Scholars

Published In

Circ Cardiovasc Genet

DOI

EISSN

1942-3268

Publication Date

April 2016

Volume

9

Issue

2

Start / End Page

185 / 188

Location

United States

Related Subject Headings

  • Ticlopidine
  • Thrombosis
  • Stents
  • Platelet Aggregation Inhibitors
  • Pharmacogenetics
  • Myocardial Infarction
  • Middle Aged
  • Male
  • Humans
  • Genotype
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Pereira, N. L., Geske, J. B., Mayr, M., Shah, S. H., & Rihal, C. S. (2016). Pharmacogenetics of Clopidogrel: An Unresolved Issue. Circ Cardiovasc Genet, 9(2), 185–188. https://doi.org/10.1161/CIRCGENETICS.115.001318
Pereira, Naveen L., Jeffrey B. Geske, Manuel Mayr, Svati H. Shah, and Charanjit S. Rihal. “Pharmacogenetics of Clopidogrel: An Unresolved Issue.Circ Cardiovasc Genet 9, no. 2 (April 2016): 185–88. https://doi.org/10.1161/CIRCGENETICS.115.001318.
Pereira NL, Geske JB, Mayr M, Shah SH, Rihal CS. Pharmacogenetics of Clopidogrel: An Unresolved Issue. Circ Cardiovasc Genet. 2016 Apr;9(2):185–8.
Pereira, Naveen L., et al. “Pharmacogenetics of Clopidogrel: An Unresolved Issue.Circ Cardiovasc Genet, vol. 9, no. 2, Apr. 2016, pp. 185–88. Pubmed, doi:10.1161/CIRCGENETICS.115.001318.
Pereira NL, Geske JB, Mayr M, Shah SH, Rihal CS. Pharmacogenetics of Clopidogrel: An Unresolved Issue. Circ Cardiovasc Genet. 2016 Apr;9(2):185–188.

Published In

Circ Cardiovasc Genet

DOI

EISSN

1942-3268

Publication Date

April 2016

Volume

9

Issue

2

Start / End Page

185 / 188

Location

United States

Related Subject Headings

  • Ticlopidine
  • Thrombosis
  • Stents
  • Platelet Aggregation Inhibitors
  • Pharmacogenetics
  • Myocardial Infarction
  • Middle Aged
  • Male
  • Humans
  • Genotype